ISMPP Highlights
Educational Series on Data and Financial Transparency – A Project of the Global Transparency Committee
As reported in January 2017 in The MAP newsletter, one of the goals of the ISMPP Global Transparency Committee was to “develop an educational series designed to educate members and provide them with real-world resources to inform their worldwide approaches to data and financial transparency…”
The BMJ Posts ISMPP Response to First Industry Analysis of Clinical Trial Transparency Policies
The BMJ posted ISMPP’s Rapid Response on August 9, 2017, to an informative article titled, “Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study,” authored by Goldacre and colleagues, and published in The BMJ on July 26, 2017…
ISMPP Introduces New Student Membership
ISMPP has introduced a new Student Membership category, expanding its membership offerings to welcome future medical publication professionals. The Society has been exploring Student Membership for the past year, and ultimately decided to proceed with this new membership category to…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Beware the Imposter: Predatory Conferences Lure the Unsuspecting
Predatory conferences are “for-profit, low-quality academic meetings that exploit researchers’ need to share and publish their research” (1) and have been variously described as “questionable” (2), “fraudulent, bogus” (3), “fake” (4), “scam” (5), “dubious” (6), “scientifically bankrupt” (7), and “the dark side of the open access movement” (8). Predatory conferences are…
Successful Publication Steering Committees: Practice Pearls from Biopharmaceutical and Agency Perspectives
In the context of company-sponsored medical research, Good Publication Practice guidelines (GPP3) recommend the use of publication steering committees (PSCs) to “plan and oversee the development of publications and presentations from a study or group of studies.” A PSC is…
Engaging the Audience: The Importance of Targeting the Reader When Creating Impactful Scientific Publications
As medical publication professionals, we know the importance of disseminating scientific information clearly and accurately. We work methodically and meticulously on each publication (or publication plan), striving to ensure that the final product is comprehensive, transparent, and ethical…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL: The Authorship Order Dilemma
You are a company medical publication professional. The publication steering committee of a company-sponsored pivotal phase 3 clinical trial has selected investigators to serve as authors, but the committee and authors are having difficulty in deciding the order of authorship. During discussions, multiple authors believe that they have equal rights to the first author position based on their contributions…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals